Celularity Inc. , a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases.
Celularity stock last closed at $4.94, down 1.79% from the previous day, and has decreased 11.47% in one year. It has underperformed other stocks in the Biotechnology industry by 0.06 percentage points. Celularity stock is currently +210.69% from its 52-week low of $1.59, and -44.49% from its 52-week high of $8.90.
As of Mar 27, 2024, there are 19.38M CELU shares outstanding. The market value of CELU is $95.73M. In the last 24 hours, 32,541 CELU shares were traded.
How to Buy Celularity Stock
Wondering how to invest in Celularity stock? Here's how.
Figure out where to buy Celularity stock: You need to choose a stock brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you determine where to buy Celularity stock.
Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Fund your investment account: Select your payment method and add your information.
Analyze Celularity stock: The Celularity ticker symbol is CELU. Is Celularity stock a good investment? Should you buy shares of CELU? How do CELU's underlying business fundamentals look? Do top analysts think Celularity is a good buy? Why has CELU's stock price moved recently? (Hint: Our stock market analysis website can help you decide if CELU is a good stock to buy).
Place your CELU trade: Decide if you will purchase CELU shares at the current market price or use a limit order to buy CELU stock at a particular price.
Get the latest scoop on your CELU position: Create a watchlist to get live updates on your position in Celularity shares.
Step 1: Figure out where to buy Celularity stock
You need an online brokerage account in order to access the NASDAQ market and buy CELU stock.
A brokerage account allows you to buy and sell a variety of investments, such as stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best online stock brokerage. Here's why:
You can invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
Access to global financial markets: From Technology to Real Estate, New York to Tokyo — you can fill your portfolio with stocks from the globe's leading stock exchanges.
Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by creating an account with eToro today.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've picked the best brokerage, you'll need to fill out some personal information so you are able to invest in CELU stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Celularity stock
Once you have figured out the best place to buy Celularity stock, it's critical to evaluate their stock prior to investing, so you truly wrap your head around the risk as well as the upside.
Overview of key CELU info
CELU Price
$4.94
1w %
-9.69%
1y %
-11.47%
5y %
N/A
P/E
-0.49x
P/B
3.16x
P/S
6.29x
PEG
N/A
Revenue
$14.79M
Earnings
-$181.41M
Fore. Rev. Growth
73.55%
Fore. Earn. Growth
N/A
Market Cap
$95.73M
Next Earnings
Mar 29, 2024
Next Dividend
N/A
CELU Fundamentals
WallStreetZen was built to help average investors do more in-depth fundamental analysis in minutes instead of hours.
Last year, CELU revenue was $14.79M. Over the last 3 year, CELU's revenue has gone up by -81.46% per year. This was slower than the Biotechnology industry average of 29.77%.
Are CELU executives and large shareholders buying or selling the stock?
Over the last year, insiders at CELU have bought more shares than they have sold.
Kyle Fletcher, Executive Vice President General Counsel of CELU, was the latest CELU insider to sell. They sold $3,504.56 worth of CELU stock on Mar 15, 2024.
No, Celularity doesn't provide an income stream by paying out dividends.
What others are saying about CELU
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Place your CELU trade
There are two main types of orders:
Market order: A market order is an order to buy or sell a stock at the best price on the market. Market orders are mostly the best for newer investors.
Limit order: A limit order lets you buy or sell a stock at a specific price (or better). If you want to be sure you're buying or selling at a particular dollar amount, place a limit order.
Press the Open Trade button and your broker will execute your order.
If you require additional help investing in stocks on eToro, click the helpful video below:
How much does it cost to buy one Celularity share?
As of Mar 27, 2024, it costs $4.94 to buy one share of Celularity stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $2, you can buy 0.405 shares of CELU.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.